Health · 1 views
New survey highlights persistent cancer medication shortages across United States
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States.
Summary
The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States. The data come from survey responses from pharmacy directors and other clinical and administrative leaders at NCCN Member Institutions from late August. According to the results, 100% of responding cancer centers are experiencing a shortage of at least one anticancer agent, with more than 20% of centers currently experiencing shortages of five or more different medications.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- My plea to MPs: this is the final chance to save the assisted dying bill. Make your mark on history | Polly ToynbeeContinue reading
- Blood protein analysis suggests a lung disease drug could be fighting aging at the same timeContinue reading
- Beyond B cells: Rituximab response may reveal which kidney disease patients can stop steroidsContinue reading
- Can a tick bite create a meat allergy and increase heart disease risk?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow